Mistletoe Therapy

Contact Now!

Responsive image

Mistletoe Therapy

Mistletoe products are made from the white-berry mistletoe which grows on a variety of deciduous and coniferous trees. The mistletoe behaves very differently from all other plants:

  • It is an evergreen that blooms and reproduces in winter.
  • It does not grow in the earth – it’s a semi-parasite that lives on trees.
  • It has no roots, only a so-called “sinker” that connects the mistletoe to the host tree.
  • Its growth is independent from sun and gravity, so its branches grow out into all directions – giving it a spherical shape. No other plant grows in this way.

In Europe, there are three subspecies of white-berry mistletoe: deciduous tree, pine and fir mistletoe. Helixor produces mistletoe extracts for fir mistletoe, the apple tree mistletoe and pine mistletoe.

The mistletoe contains over 1,000 different constituents. Its effects on the immune system and the tumor-inhibiting properties of mistletoe extracts are primarily due to a glycoprotein called lectin (specifically three sub-groups: mistletoe lectin I, II, and III).

Different mistletoe subspecies have different lectin patterns. Pine mistletoe, for example, has no mistletoe lectin I, but large amounts of mistletoe lectin III, while apple tree mistletoe primarily contains mistletoe lectin. I Scientific studies show that it is important to consider the effect of the whole extract. Other constituents include viscotoxins (special polypeptides) and complex carbohydrates (polysaccharides), which also show immunostimulatory effects and can complement or enhance the action of lectins. Arginine (an amino acid), flavonoids (secondary plant metabolites), and a high level of vitamin C also contribute to immunomodulation.

Therapeutic Application of

Mistletoe Therapy

  • Early malignancies. Here it has the greatest scope, especially in Stage 0, i.e Carcinoma-in-situ.
  • Advanced malignancies. Here it is of considerable help in inoperable tumours, recurrences, widespread metastases and in terminal cases, it brings about palliation.
  • It is used as a prophylactic for malignant lesions in pre-cancerous states, where regression of the lesions take place.
  • Benign neoplasms.
  • Surgery-Inoperable tumours become operable through delineation of the tumours by Mistletoe therapy. During the operation, it hastens a smooth convalescence. Early follow-up treatment by Mistletoe results in a significant reduction in the incidence of recurrences and late metastases by about 30-40%.
  • Concurrent with chemotherapy and/or radiation, Mistletoe prevents or reduces toxic side effects, promotes tolerance as well as dispersion of the tumours.
Responsive image
Responsive image

Reactions Under Mistletoe Therapy

  • Inflammatory reaction with increased flow of blood and swelling in the region of the rumors is seen occasionally with usual subcutaneous injection. This passes off in a few hours.
  • Slight increase in body temperature occurs which is desirable as a curative process.
  • Transient increase in the neutrophil component of white blood cell count, which persists for some hours.
  • Immune stimulation as a whole and consequent inhibition of tumours development which lead to :
    1. Improvement in the general condition.
    2. Increased appetite.
    3. Gain in weight.
    4. Improve sleep.
    5. Decrease in fatigue and depression.
    6. Stimulation of urinary and bowel functions.
    7. Reduction of disappearance of pain.
  • Increase tolerance to irradiation and/or chemotherapy.
  • Relief of pain & subjective improvement in patient are most striking even in advanced stages of cancer and in spite of the progressive course of the tumour.
  • Very rarely oral suspension (varumin) causes diarrhea.

Potential Of Mistletoe Therapy

Mistletoe potentiates the action of chemo therapeutics as both act on the immune mechanism, when understood and practiced, these therapies become limitless in their possibilities for development and their power to treat the millions of sick people in the world.